Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 0
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 15-304
Study First Received: December 18, 2015
Last Updated: December 5, 2016
Estimated Primary Completion Date: December 2016
Primary Outcome Measures:
Dose limiting toxicities (DLT)
Sponsors and Collaborators:
Memorial Sloan Kettering Cancer Center
Website Link: https://ClinicalTrials.gov/show/NCT02639767
